Lannett Co. announces patent approval for generic pain drugs

PHILADELPHIA Generic drug maker Lannett Company announced earlier this month that the United States Patent and Trademark Office granted a patent to subsidiary Cody Laboratories for a method for preparing hydromorphone and hydrocodone.

“Our patented method for preparing hydromorphone and hydrocodone will greatly enhance our ability to manufacture these products quickly and efficiently,” Lannett president and chief executive Arthur Bedrosian said. “Importantly, with minimal incremental investment, the faster manufacturing time appreciably expands our manufacturing capacity, allowing us to maximize our production assets.”

Hydromorphone and hydrocodone are opiate-derived drugs used for treating pain.